BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19487459)

  • 41. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in cyclin dependent kinase expression and activity accompanying lens fiber cell differentiation.
    Gao CY; Rampalli AM; Cai HC; He HY; Zelenka PS
    Exp Eye Res; 1999 Dec; 69(6):695-703. PubMed ID: 10620399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?
    Fesquet D; Morin N; Doree M; Devault A
    Oncogene; 1997 Sep; 15(11):1303-7. PubMed ID: 9315098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H.
    Schneider E; Kartarius S; Schuster N; Montenarh M
    Oncogene; 2002 Aug; 21(33):5031-7. PubMed ID: 12140753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower cyclin H and cyclin-dependent kinase-activating kinase activity in cell cycle arrest induced by lack of adhesion to substratum.
    Solorzano L; Rieber MS; Rieber M
    Cancer Res; 2000 Dec; 60(24):7114-8. PubMed ID: 11156419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex.
    Park M; Krause MW
    Development; 1999 Nov; 126(21):4849-60. PubMed ID: 10518501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.
    Hirai H; Sherr CJ
    Mol Cell Biol; 1996 Nov; 16(11):6457-67. PubMed ID: 8887674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
    Paternot S; Arsenijevic T; Coulonval K; Bockstaele L; Dumont JE; Roger PP
    Cell Cycle; 2006 Jan; 5(1):61-70. PubMed ID: 16294008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.
    Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P
    Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
    Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
    Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Meyerson M; Harlow E
    Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice.
    Hampl A; Pacherník J; Dvorák P
    Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
    Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
    Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin D-cdk6 complex is targeted by p21(WAF) in growth-arrested lymphoma cells.
    Tvrdík D; Djaborkhel R; Nagy A; Eckschlager T; Raska I; Müller J
    J Struct Biol; 2002; 140(1-3):49-56. PubMed ID: 12490153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.
    Fry DW; Bedford DC; Harvey PH; Fritsch A; Keller PR; Wu Z; Dobrusin E; Leopold WR; Fattaey A; Garrett MD
    J Biol Chem; 2001 May; 276(20):16617-23. PubMed ID: 11278443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
    Arsenijevic T; Degraef C; Dumont JE; Roger PP; Pirson I
    Biochem J; 2004 Mar; 378(Pt 2):673-9. PubMed ID: 14641107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.